VITAL VOICES HONORS WOMEN LEADING THE RISE AT 3RD ANNUAL FESTIVAL & 23RD ANNUAL GLOBAL LEADERSHIP AWARDS IN WASHINGTON, DC FROM MAY 29 to 30 28-05-2024, 21:55

Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer 11-05-2023, 03:05

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26